Clinical Trial Update: Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis [Phase 1]

View source ↗

Summary

Phase 1 trial of pomalidomide with melphalan and dexamethasone for untreated systemic AL amyloidosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Al Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Melphalan (Melphalan)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloma | Phase 1 | Status: TERMINATED